Liezl Gambe

A broad selloff erased billions in market value Tuesday as investors retreated from high-flying technology stocks, spooked by President Trump’s escalating trade war threats against European allies.

Phio Pharmaceuticals (NASDAQ:PHIO) reported that its experimental gene-silencing therapy cleared tumors in the majority of patients during a mid-stage study, marking a significant win for its proprietary INTASYL technology.

Celcuity (NASDAQ:CELC) shares rose in premarket trading Tuesday after the U.S. Food and Drug Administration accepted the New Drug Application for gedatolisib, a potential first-in-class therapy for patients with advanced breast cancer.

Boeing (NYSE:BA) secured a significant commitment from Ethiopian Airlines Group for 20 aircraft, as Africa's largest carrier moves to modernize its fleet and broaden its reach across four continents.

3M (NYSE:MMM) delivered fourth-quarter results on Tuesday that underscored the industrial giant’s successful shift toward operational leaness, as adjusted operating margins reached 21.1%—a 140-basis-point improvement over the previous year.

Marietta, Ohio-based Peoples Bancorp (NASDAQ:PEBO) reported strong fourth-quarter 2025 financial results, highlighted by record net income of $31.8 million, or $0.89 per diluted share, compared with $26.9 million ($0.76 per share) in the fourth quarter of 2024 and $29.5 million ($0.83 per share) in the third quarter of 2025.

Solana ETFs saw fresh outflows as SOL broke lower, signalling weakening confidence and rising downside risk.

Ripple argues that regulation is transforming stablecoins into a permanent, supervised part of the global financial system.

Wintermute says structural forces, not cycles, will determine crypto price movements as the market matures in 2026.

Peter Brandt says weakening fiat currencies could drive altcoins into deeper decline as gold regains its role as a global store of value.